Evidence map›Paper›PMID 42846115›Full record

ArticleFrontiers in health services2026

Lorella Palazzo, Casey Luce, Anjali Vasavada, Kayne Mettert, Hongyuan Gao, James D Ralston, Nadejda Bezman, Beverly B Green, Kristine Rogers, Melissa L Anderson and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in health services, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05747443 (Multilevel Interventions to Increase Adherence to Lung Cancer Screening), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05747443 naactive not recruitingnot on this map

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

TypeinterventionalSponsorKaiser PermanenteRan2022 to 2026Enrolled1,837ConditionsLung Cancer, Lung Cancer ScreeningArmsStepped Reminders, Patient Education
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lorella PalazzoKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
Casey LuceKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
Anjali VasavadaKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
Kayne MettertKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
Hongyuan GaoKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
James D RalstonKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
Nadejda BezmanKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
Beverly B GreenKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
Kristine RogersKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
Melissa L AndersonKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
Yu-Ru SuKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
Matthew TripletteUniversity of Washington, Seattle, WA, United States.
Lisa Carter-BawaCenter for Discovery and Innovation at Hackensack Meridian Health, Nutley, NJ, United States.
Karen J WernliKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.

Funding

Patient Provider Communication Larch SupplementR01CA262015 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI WERNLI, KAREN J · 2021 to 2025
$3.3M
NCI NIH HHS R01 CA262015
6 · The paper itself

Abstract

Introduction: Low adherence to annual lung cancer screening (LCS) has tempered mortality benefits in clinical practice. Herein, we assessed the acceptability and appropriateness of two patient-centered interventions addressing adherence barriers to annual LCS. Methods: Participants were Kaiser Permanente Washington members, aged 50-78 years, who participated in a pragmatic randomized trial ("The Larch Trial"). The trial tested: (1) health communication including a video to improve patient knowledge of timeliness to return; and (2) outreach reminders to patients to schedule annual screenings after their primary care provider (PCP) ordered a scan without an appointment. Participants, randomly sampled on sex, race/ethnicity, tobacco status, and trial arm, completed semistructured, virtual interviews that lasted for 60 min. The interviews explored intervention acceptability and appropriateness, and barriers and facilitators to both. Transcripts were analyzed using a rapid group analysis process informed by the Consolidated Framework for Implementation Research. Identified themes were second-coded for acceptability and appropriateness in accordance with the Implementation Outcomes Framework. Results: A total of 32 participants were interviewed; 66% were non-Hispanic white, 53% male, and 53% currently use tobacco. The participants found the interventions acceptable and appropriate with variations by LCS history and information needs. Some participants found the video helpful and comforting, especially first-time screeners. Other participants, particularly those engaged in annual LCS, found that the video lacked new information. The participants strongly endorsed the reminder intervention for encouraging LCS and clarifying the timing of repeat screening. Most participants endorsed the annual screening scan ordered without a PCP visit. The participants preferred the multimodal delivery of reminders for reinforcement. Facilitators of acceptability and appropriateness included video design and perceived educational value, and an electronic health record ecosystem supporting communication aligned with routine practice. Barriers included content perceived as not novel, lack of information to address specific needs, and excessive reminders. Discussion: Video-based content in LCS is generally acceptable and appropriate to patients if tailored by LCS history. Patient outreach reminders are acceptable and appropriate when mirroring other healthcare system communications. Participants already engaged in LCS did not feel they needed to see their PCP one year later for repeat screening (within 1 year). Future studies should test interventions in other populations and healthcare systems using different communication strategies. Clinical trial registration: clinicaltrials.gov, identifier #NCT05747443.

Indexed as

acceptabilityappropriatenesscancer screeninghealth communicationimplementationlung neoplasmpatientpragmatic clinical trial

Identifiers

PMID42846115
PMCPMC13642276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.